Brain natriuretic peptide increases acutely and much more prominently than atrial natriuretic peptide during coronary angioplasty

Clinical Cardiology

Volumn 23, Issue 4, 2000, Pages 285-288

  Kyriakides, Zenon S ^a,c   Markianos, Manolis ^b   Michalis, Lambros ^a   Antoniadis, Aias ^a   Nikolaou, Nikolaos I ^a   Kremastinos, Dimitrios T ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^c ONASSIS CARDIAC SURGERY CENTER   (Greece)

Author keywords

Atrial natriuretic peptide; Brain natriuretic peptide; Coronary angioplasty

Indexed keywords

ACETYLSALICYLIC ACID; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CYCLIC AMP; CYCLIC GMP; HEPARIN; NITRATE;

ADULT; AGED; ANGIOPLASTY; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; FEMALE; HEART LEFT VENTRICLE FUNCTION; HUMAN; MALE; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; VASODILATATION;

EID: 0034111147     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960230412     Document Type: Article

References (22)

1. Sudoh T, Kangawa K, Minamino N, Matsuo H: A new natriuretic peptide in porcine brain. Nature 1988;332:78-81
2. Kambayashi Y, Nakao K, Mukoyama M.,Saito Y, Ogawa Y, Shioo S, Inouye K, Yoshida N, Imura H: Isolation and sequence determination of human brain natriuretic peptide in human atrium. FEBS Lett 1990;259:341-345
3. Aburaya M, Hino J, Minamino N, Kangawa K, Matsuo H: Isolation and identification of rat brain natriuretic peptides in cardiac atrium. Biochem Biophys Res Commun 1989;163:226-232
4. Kohno M, Horio T, Yokokawa K, Murakawa K, Yasunari K, Akioka K, Tahara A, Toda I, Takeuchi K, Kurihara N, Tanaka H: Brain natriuretic peptide as a cardiac hormone in essential hypertension. Am J Med 1992;92:29-34
5. Horio T, Kohno M, Takeda T: Effects of arginine vasopressin, angiotensin II and endothelin-1 on the release of brain natriuretic peptide in vivo and in vitro. Clin Exp Pharmacol Physiol 1992;19: 575-582
6. Mukoyama M, Nakao K. Saito Y: Increased human brain natriuretic peptide in congestive heart failure. N Engl J Med 1990;323: 757-758
7. Horio T, Shimada K, Kohno M, Hoshimura T, Kawarabayashi T, Yasunari K, Murakawa K, Yokokawa K, Ikeda M, Fukui T, Takeda T: Serial changes in atrial and brain natriuretic peptides in patients with acute myocardial infarction treated with early coronary angioplasty. Am Heart J 1993;126:293-299
8. Uehata A, Matsuguchi T, Bittl JA, Orav J, Meredith IT, Anderson TJ, Selwyn AP, Ganz P, Yeung AC: Accuracy of electronic digital calipers compared with quantitative angiography in measuring coronary arterial diameter. Circulation 1993;88:724-729
9. Kyriakides ZS, Markianos M, Iliodromitis EK, Kremastinos DT: Vein plasma endothelin-1 and cyclic GMP increase during coronary angioplasty is related to myocardial ischemia. Eur Heart J 1995;16:894-898
10. Kyriakides ZS, Markianos M, Antoniadis A, Sbarouni E, Nikolaou N, Zarvalis E, Michalis L, Triantafillou K, Kremastinos DT: Effect of rotational coronary atherectomy on peripheral endothelin-1, atrial natriuretic peptide and cyclic adenosine monophosphate plasma levels. Caidiovasc Drugs Ther 1998;12:245-250
11. Mukoyama M, Nakao K, Saito Y, Ogawa Y, Hosoda K, Suga S, Shirakami G, Jougasaki M, Obata K, Yasue H, Kambayashi Y, Inouye K, Imura H: Brain natriuretic peptide (BNP) as a novel cardiac hormone in humans: Evidence for an exquisite dual natriuretic peptide system, ANP and BNP. J Clin Invest 1991;87:1402-1412
12. Edwards BS, Zimmerman RS, Schwab TR, Heublein DM, Burnett JC: Atrial stretch, not pressure, is the principal determinant controlling the acute release of atrial natriuretic peptide. Circ Res 1988;62: 191-195
13. Yasue H, Yosnimura M, Sumida H, Kikuta K, Kugiyama K, Jougasaki M, Ogawa H, Okumura K, Mukoyama M, Nakao K: Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994;90:195-203
14. Richards AM: The renin-angiotensin-aldosterone system and the cardiac natriuretic peptides. Heart 1996;76(suppl 3):36-44
15. Mukoyama M, Nakao K, Saito Y, Ogawa Y, Hosoda K, Suga S, Shirakami G, Jougasaki M, Imura H: Human brain natriuretic peptide, a novel cardiac hormone. Lancet 1990;335:801-802
16. Yoshimura M, Yasue H, Morita E, Sakaino N, Jougasaki M, Kurose M, Mukoyama M, Saito Y, Nakao K, Imura H: Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure. Circulation 1991;84: 1581-1588
17. Okumura K, Yasue H, Fuji H, Kugiyama K, Matsuyama K, Hoshimura M, Jougasaki M, Kikuta K, Kato H, Tanaka H, Sumita H, Nakao K: Effects of brain (B-type) natriuretic peptide on coronary artery diameter and coronary hemodynamic variables in humans: Comparison with effects on systemic hemodynamic variables. J Am Coll Cardiol 1995;25:342-348
18. Bonow RO: New insights into the cardiac natriuretic peptides. Circulation 1996;93:1946-1950
19. Williams MJ, Dow CJ, Newell JB, Palacios IF, Picard MH: Prevalence and timing of regional myocardial dysfunction after rotational coronary atherectomy. J Am Coll Cardiol 1996;28:861-869
20. Ball JH, Kaminsky NI, Hardman JG, Broadus AE, Sutherland EW, Liddle GW: Effects of catecholamines and adrenergic-blocking agents on plasma and urinary cyclic nucleotides in man. J Clin Invest 1972;51:2124-2128
21. Kunitada S, Honma M, Ui M: Increases in plasma cyclic AMP dependent on endogenous catecholamines. Eur J Pharmacol 1978; 48:159-169
22. Ameli S, Kaul S, Castro L, Arora C, Mirea A, Shah PK: Effect of percutaneous transluminal coronary angioplasty on circulating endothelin levels. Am J Cardiol 1993;72:1352-1356